Challenges and opportunities in improving the management of atrial fibrillation: recent research advances and their clinical translation

Cardiovasc Res. 2021 Jun 16;117(7):1609-1611. doi: 10.1093/cvr/cvab170.

Stanley Nattel^{1

2

3

4}, Gregory Y H Lip^{5

6}, David Filgueiras-Rama⁷, Dobromir Dobrev^{1

4

8}

¹ Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, 3655 Promenade Sir William Osler, Montreal QC, H3G 1Y6, Canada.
² Department of Pharmacology and Therapeutics, McGill University, 5000 Belanger St E, Montreal, Quebec H1T 1C8, Canada.
³ IHU LIRYC and Fondation Bordeaux Université, Avenue du Haut Lévêque, 33600 Pessac, Bordeaux, France.
⁴ Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Hufelandstr. 55, 45122-Essen, Germany.
⁵ Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool L7 8TX, UK.
⁶ Department of Clinical Medicine, Aalborg University, Sondre Skovvej 15, 9000 Aalborg, Denmark.
⁷ Myocardial Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Cardiovascular Institute, Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Melchor Fernández Almagro 3, Madrid 28029, Spain.
⁸ Department of Molecular Physiology & Biophysics, Baylor College of Medicine, One Baylor Plaza, BCM335, Houston, TX, 77030, USA.

No abstract available

Publication types